Eagle Pharmaceuticals Market Cap

Eagle Pharmaceuticals has a market cap or net worth of $46.23 million as of July 11, 2025. Its market cap has increased by 3.94% in one year.

Market Cap

46.23M

Enterprise Value

n/a

Revenue

257.55M

Ranking

n/a

PE Ratio

3.89

Stock Price

$3.55

Market Cap Chart

Since February 12, 2014, Eagle Pharmaceuticals's market cap has increased from 39.11M to 46.23M, an increase of 18.22%. That is a compound annual growth rate of 1.48%.

Market Cap History

Date	Market Cap	% Change
Jul 10, 2025	46.23M	610.00%
Dec 31, 2024	6.51M	-90.41%
Dec 29, 2023	67.92M	-82.15%
Dec 30, 2022	380.45M	-42.14%
Dec 31, 2021	657.57M	8.37%
Dec 31, 2020	606.81M	-26.12%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Endo, Inc.	1.60B
Veradigm	857.64M
Nika Pharmaceuticals	708.22M
Tian'an Technology Group	628.15M
Elite Pharmaceuticals	553.58M
Glass House Brands	545.56M
CytoDyn	394.14M
American Oncology Network	343.79M

Market Cap Rankings